Triangle
Your health history, in one place. Yours to control.
Triangle brings your medical records, genetic test results and readings from devices like Fitbit, Garmin, Oura or Whoop into one place. Your records become one history, organised by condition. For yourself, or for someone you care for.
A page per condition
Triangle finds the conditions in your records and builds a dated history of each one, with your medicines and notes. Add any others yourself.
Ask about all of it
Each document you add gets a summary. Ask what a result means, how it has changed, or, with a device connected, how you have been sleeping.
Ready for every visit
Ask, and your questions, key results and the plan go into one note to bring along. Triangle can also remind you about tests and medicines.
Shared on your terms
Invite family, a caregiver or a doctor. Choose whether family and caregivers can view or help manage. Remove anyone at any time.
Take it with you
Download a condition’s history as a PDF, or any file you uploaded. If you cancel, your history stays.
Deeper help with cancer
A step-by-step guide for advanced cancer, and help looking for clinical trials that may fit.
Triangle does not diagnose or treat, and it never replaces your care team. Start with the records you have →
We specialise in cancer. Every other AI is guessing.
Why did you rank the targeted combination above adding radiation?
Mostly because of the inherited TP53 finding in your germline results your sequencing, Sept 2023. Radiation spends part of a lifetime budget you can’t get back, and with that finding the risk of a second cancer later is meaningfully higher than average.
The targeted route costs you none of that budget. It also builds on the treatment you’re already having your current therapy rather than replacing it.
This is one reading of your records, not a recommendation. Your oncologist decides.
What would change your mind?
Progression on the current therapy. If the disease starts moving, the calculation flips and radiation becomes worth the budget; that’s written into option four.
What the pipeline already knows before you ask
- Ranked targeted therapies
- Matched clinical trials
- Hereditary (germline) findings
- Every alteration, tiered and evidenced
- Mutational burden and MSI
- Neoantigen candidates
- Drug metabolism, gene by gene
- Immune cell fractions
- Supplements, screened against your file
One run covers the whole patient: roughly fifty tables. Every claim Triangle makes traces to a named source in your run. When something isn’t in your file, it says so. The full pipeline →
How it works
Your records, genetics and devices go in. Clear answers come out.
Papers you already have
Biopsy and scan reports, blood tests, visit notes and hospital discharge papers. Upload PDFs, or photos of paper copies. No papers? Tell Triangle what you know, and it keeps track.
Records we request for you
Once the patient verifies their ID and gives permission, we request them from the network that links most US hospitals. A Triangle clinician then goes through them with you.
Genetic results, if you have them
Add genetic or tumour test reports, and Triangle can work their findings into the related condition’s history. Raw files from a tumour test? Members can ask our team about a deeper research analysis of supported data.
Readings from your devices
Connect a Fitbit, Garmin, Oura, Whoop or other supported device. Daily sleep, heart rate and activity readings sit beside your lab results. Disconnect whenever you like.
Medical research, when you ask
Triangle looks up studies and guidelines, favouring medical journals and health agencies, then separates what comes from your record from what is settled medicine and what is still uncertain.
Everything on the leftabove, in one place. Ask in your own words. Get answers in plain ones.
Latest
What’s new, sourced.
Dated FDA notices and posted trial results from the cancer evidence library, and the newest phase 1 explainers.
Research news
- FDA grants accelerated approval to sevabertinib for locally advanced or metastatic non-squamous non-small cell lung cancer
- A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation
- FDA grants accelerated approval to camizestrant with a CDK4/6 inhibitor for ESR1-Mutated HR-positive, HER2-negative locally advanced or metastatic breast cancer
- Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCN
- Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load
